Open Access<p>Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma</p>
Author(s) -
Qimin Tu,
Hongjian Gong,
Chunhui Yuan,
Liu Gao,
Jinqi Huang,
Zhichao Li,
Jintai Luo
Publication year - 2020
Publication title -
cancer management and research
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s263559
Subject(s) - hazard ratio , medicine , proportional hazards model , receiver operating characteristic , oncology , univariate analysis , stage (stratigraphy) , survival analysis , multivariate analysis , cancer , gastroenterology , biology , confidence interval , paleontology
p53 isoform Δ133p53 is directly transactivated by p53 and antagonizes p53 activities in cancer progression. However, its correlation with prognosis and cancer recurrence in esophageal squamous cell carcinoma (ESCC) is still unclear.